Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lucia Valmaggia is active.

Publication


Featured researches published by Lucia Valmaggia.


Schizophrenia Research | 2006

The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised model

Mark van der Gaag; Tonko Hoffman; Mila Remijsen; Ron Hijman; Lieuwe de Haan; Berno van Meijel; Peter N. van Harten; Lucia Valmaggia; Marc De Hert; Anke Cuijpers; Durk Wiersma

OBJECTIVEnThe lack of fit of 25 previously published five-factor models for the PANSS items, can be due to the statistics used. The purpose of this study was to use a new statistical method to develop and confirm an improved five-factor model. The improved model is both complex and stable. Complex means that symptoms can have multiple factor loadings, because they have multiple causes, not because they are ill defined. Stable means that the complex structure is found repeatedly in validations.nnnMETHODSnA ten-fold cross-validation (10 CV) was applied on a large data set (N = 5769) to achieve an improved factor model for the PANSS items. The advantages of 10 CV are minimal effect of sample characteristics and the ability to investigate the stability of items loading on multiple factors.nnnRESULTSnThe results show that twenty-five items contributed to the same factor all ten validations with one item showing a consistent loading on two factors. Three items were contributing to the same factor nine out of ten validations, and two items were contributing to the same factor six to eight times. The resulting five-factor model covers all thirty items of the PANSS, subdivided in the factors: positive symptoms, negative symptoms, disorganization, excitement, and emotional distress. The five-factor model has a satisfactory goodness-of-fit (Comparative Fit Index = .905; Root Mean Square Error of Approximation = .052).nnnCONCLUSIONSnThe five-factor model developed in this study is an improvement above previously published models as it represents a complex factor model and is more stable.


Molecular Psychiatry | 2011

Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study

Oliver Howes; Subrata K. Bose; Federico Turkheimer; Isabel Valli; Alice Egerton; Daniel Stahl; Lucia Valmaggia; Paul Allen; Robin M. Murray; Philip McGuire

Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study


Schizophrenia Research | 2006

The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions

Mark van der Gaag; Anke Cuijpers; Tonko Hoffman; Mila Remijsen; Ron Hijman; Lieuwe de Haan; Berno van Meijel; Peter N. van Harten; Lucia Valmaggia; Marc De Hert; Durk Wiersma

OBJECTIVEnThe aim of this study was to test the goodness-of-fit of all previously published five-factor models of the Positive and Negative Syndrome Scale (PANSS).nnnMETHODSnWe used confirmatory factor analysis (CFA) with a large data set (N = 5769).nnnRESULTSnThe different subsamples were tested for heterogeneity and were found to be homogeneous. This indicates that despite variability in age, sex, duration of illness, admission status, etc., in the different subsamples, the structure of symptoms is the same for all patients with schizophrenia. Although previous research has shown that a five-factor model fits the data better than models with three or four factors, no satisfactory fit for any of the 25 published five-factor models was found with CFA.nnnCONCLUSIONSnVariability in age, sex, admission status and duration of illness has no substantial effect on the structure of symptoms in schizophrenia. The lack of fit can be caused by ill-defined items that aim to measure several properties in a single rating. Another explanation is that well-defined symptoms can have two or more causes. Then a double or triple loading item should not be discarded, but included because the complexity of symptoms in schizophrenia is represented by these multiple loadings. Such a complex model not only needs confirmation by CFA, but also has to be proven stable. A 10-fold cross-validation is suggested to develop a complex and stable model.


Psychological Medicine | 2009

Economic impact of early intervention in people at high risk of psychosis

Lucia Valmaggia; Paul McCrone; Martin Knapp; James Woolley; Matthew R. Broome; Paul Tabraham; Louise Johns; Corinne Prescott; Elvira Bramon; Julia Lappin; Paddy Power; Philip McGuire

Background Despite the increasing development of early intervention services for psychosis, little is known about their cost-effectiveness. We assessed the cost-effectiveness of Outreach and Support in South London (OASIS), a service for people with an at-risk mental state (ARMS) for psychosis. nMethod The costs of OASIS compared to care as usual (CAU) were entered in a decision model and examined for 12- and 24-month periods, using the duration of untreated psychosis (DUP) and rate of transition to psychosis as key parameters. The costs were calculated on the basis of services used following referral and the impact on employment. Sensitivity analysis was used to test the robustness of all the assumptions made in the model. nResults Over the initial 12 months from presentation, the costs of the OASIS intervention were £1872 higher than CAU. However, after 24 months they were £961 less than CAU. nConclusions This model suggests that services that permit early detection of people at high risk of psychosis may be cost saving.


European Psychiatry | 2005

Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state.

Matthew R. Broome; James Woolley; Louise Johns; Lucia Valmaggia; Paul Tabraham; Rafael Gafoor; Elvira Bramon; Philip McGuire


Schizophrenia Research | 2004

The data-gathering bias in the at-risk mental state (ARMS) for psychosis

Matthew R. Broome; Louise Johns; James Woolley; C. Brett; Paul Tabraham; Lucia Valmaggia; Elvira Bramon; Emmanuelle Peters; Philippa Garety; Philip McGuire


Schizophrenia Research | 2006

0135 VERBAL SELF-MONITORING IN PEOPLE AT HIGH RISK OF PSYCHOSIS

Paul Allen; L.C. Johns; Matthew R. Broome; James Woolley; Paul Tabraham; Lucia Valmaggia; Fern Day; Oliver Howes; Til Wykes; P.K. McGuire


Schizophrenia Bulletin | 2009

A FURTHER EXPLORATION OF THE GENDER DIFFERENCES IN THE AGE OF ONSET OF SCHIZOPHRENIA

Fern Day; C. Pugh; Lucia Valmaggia; Majella Byrne; S. Bhattacharyya; Philip McGuire


Schizophrenia Research | 2006

0110 VIRTUAL REALITY AND PARANOID IDEATIONS

Lucia Valmaggia; C. Green; Daniel Freeman; Philippa Garety; Corinne Prescott; Matthew R. Broome; James Woolley; L.J. Johns; Paul Tabraham; P.K. McGuire


Schizophrenia Research | 2006

Volumetric and white matter abnormalities in the prodromal and first episode phases of psychosis

James Woolley; Gareth J. Barker; X Chitnis; Matthew R. Broome; L.C. Johns; Paul Tabraham; Elvira Bramon-Bosch; Lucia Valmaggia; Paddy Power; Lu Wang; James Semple; Steven Williams; Philip McGuire

Collaboration


Dive into the Lucia Valmaggia's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

L.C. Johns

Oxford Health NHS Foundation Trust

View shared research outputs
Top Co-Authors

Avatar

Mark van der Gaag

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elvira Bramon

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge